Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Int J Biol Sci 2021; 17(3):869-881. doi:10.7150/ijbs.56152 This issue Cite

Research Paper

MLKL inhibits intestinal tumorigenesis by suppressing STAT3 signaling pathway

Qun Zhao1,3✉, Xinran Cheng1, Jian Guo1, Yun Bi1, Li Kuang2, Jianhua Ren2, Jing Zhong1, Longrui Pan1, Xudong Zhang1, Yang Guo1, Yongqiang Liu4, Shu Jin5, Yan Tan1, Xianjun Yu1✉

1. Laboratory of Inflammation and Molecular Pharmacology, Hubei Key Laboratory of Embryonic Stem Cell Research, School of Basic Medical Sciences & Biomedical Research Institute, Hubei University of Medicine, Shiyan 442000, China.
2. Department of Oncology, Affiliated Dongfeng Hospital, Hubei University of Medicine, Shiyan 442000, China.
3. State Key Laboratory of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
4. Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
5. Department of Gastroenterology, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, China.

✉ Corresponding authors: Qun Zhao, Laboratory of Inflammation and Molecular Pharmacology, Hubei Key Laboratory of Embryonic Stem Cell Research, School of Basic Medical Sciences & Biomedical Research Institute, Hubei University of Medicine, Shiyan More

Citation:
Zhao Q, Cheng X, Guo J, Bi Y, Kuang L, Ren J, Zhong J, Pan L, Zhang X, Guo Y, Liu Y, Jin S, Tan Y, Yu X. MLKL inhibits intestinal tumorigenesis by suppressing STAT3 signaling pathway. Int J Biol Sci 2021; 17(3):869-881. doi:10.7150/ijbs.56152. https://www.ijbs.com/v17p0869.htm
Other styles

File import instruction

Abstract

Graphic abstract

Mixed lineage kinase domain-like protein (MLKL) plays an important role in necroptosis, but the role and mechanism of MLKL in intestinal tumorigenesis remain unclear. Here, we found that hematopoietic- and nonhematopoietic-derived MLKL affected intestinal inflammation, but nonhematopoietic-derived MLKL primarily inhibited intestinal tumorigenesis. Loss of MLKL enhanced intestinal regeneration and the susceptibility to intestinal tumorigenesis in Apcmin/+ mice by hyperactivating the Janus kinase 2 (JAK2)/ signal transducer and activator of transcription 3 (STAT3) axis. Furthermore, MLKL deficiency increased interleukin-6 (IL-6) production in dendritic cells. Administration of anti-IL-6R antibody therapy reduced intestinal tumorigenesis in Apcmin/+Mlkl-/- mice. Notably, low MLKL expression in human colorectal tumors, which enhanced STAT3 activation, was associated with decreased overall survival. Together, our results reveal that MLKL exhibits a suppressive effect during intestinal tumorigenesis by suppressing the IL-6/JAK2/STAT3 signals.

Keywords: Intestinal tumorigenesis, MLKL, IL-6/STAT3, Anti-IL-6R antibody therapy.

Citation styles

APA
Zhao, Q., Cheng, X., Guo, J., Bi, Y., Kuang, L., Ren, J., Zhong, J., Pan, L., Zhang, X., Guo, Y., Liu, Y., Jin, S., Tan, Y., Yu, X. (2021). MLKL inhibits intestinal tumorigenesis by suppressing STAT3 signaling pathway. International Journal of Biological Sciences, 17(3), 869-881. https://doi.org/10.7150/ijbs.56152.

ACS
Zhao, Q.; Cheng, X.; Guo, J.; Bi, Y.; Kuang, L.; Ren, J.; Zhong, J.; Pan, L.; Zhang, X.; Guo, Y.; Liu, Y.; Jin, S.; Tan, Y.; Yu, X. MLKL inhibits intestinal tumorigenesis by suppressing STAT3 signaling pathway. Int. J. Biol. Sci. 2021, 17 (3), 869-881. DOI: 10.7150/ijbs.56152.

NLM
Zhao Q, Cheng X, Guo J, Bi Y, Kuang L, Ren J, Zhong J, Pan L, Zhang X, Guo Y, Liu Y, Jin S, Tan Y, Yu X. MLKL inhibits intestinal tumorigenesis by suppressing STAT3 signaling pathway. Int J Biol Sci 2021; 17(3):869-881. doi:10.7150/ijbs.56152. https://www.ijbs.com/v17p0869.htm

CSE
Zhao Q, Cheng X, Guo J, Bi Y, Kuang L, Ren J, Zhong J, Pan L, Zhang X, Guo Y, Liu Y, Jin S, Tan Y, Yu X. 2021. MLKL inhibits intestinal tumorigenesis by suppressing STAT3 signaling pathway. Int J Biol Sci. 17(3):869-881.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use